Loading insider details...
Beta
Latest Form 4 (Oct 17, 2026): Exercise/Conversion of 25,000 BEAM shares, $25.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 17, 2026 | Beam Therapeutics Inc. (BEAM) | Exercise/Conversion | 25,000 | $25.8K |
| Jul 1, 2026 | Beam Therapeutics Inc. (BEAM) | Exercise/Conversion | 18,663 | $12.5K |
| Apr 6, 2026 | Beam Therapeutics Inc. (BEAM) | Sale | 30,078 | $739.3K |
| Apr 1, 2026 | Beam Therapeutics Inc. (BEAM) | Exercise/Conversion | 25,000 | $16.8K |
| Feb 2, 2026 | Beam Therapeutics Inc. (BEAM) | Exercise/Conversion | 19,336 | $13.0K |
| Oct 3, 2025 | Beam Therapeutics Inc. (BEAM) | Exercise/Conversion | 25,000 | $16.8K |
| Apr 4, 2025 | Beam Therapeutics Inc. (BEAM) | Sale | 30,663 | $562.7K |
| Apr 2, 2025 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 77,500 | n/a |
| Feb 3, 2025 | Beam Therapeutics Inc. (BEAM) | Sale | 29,800 | $797.0K |
| Oct 2, 2024 | Beam Therapeutics Inc. (BEAM) | Sale | 60,000 | $1.48M |